• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介导 APC 失活引起的肠道肿瘤发生增强

mediates enhancement of intestinal tumorigenesis caused by inactivation of .

机构信息

Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University München, Germany.

German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany.

出版信息

Int J Biol Sci. 2022 Aug 29;18(14):5415-5437. doi: 10.7150/ijbs.75503. eCollection 2022.

DOI:10.7150/ijbs.75503
PMID:36147476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9461672/
Abstract

The CSF1 receptor (CSF1R) encoding mRNA represents a direct target of miR-34a. However, the relevance of the suppression of by miR-34a for intestinal tumor suppression mediated by the p53/miR-34a pathway has remained unknown. Here, mice with intestinal-epithelial cell (IEC)-specific deletions of showed increased formation of adenomas and decreased survival, whereas deletion of decreased adenoma formation and increased survival. In adenomas deletion of enhanced proliferation, STAT3 signaling, infiltration with fibroblasts, immune cells and microbes, and tumor stem cell abundance and decreased apoptosis. Deletion of had the opposite effects. In addition, homeostasis of intestinal secretory and stem cells, and tumoroid formation were affected in opposite directions by deletion of and . Concomitant deletion of and neutralized the effects of the single deletions. mRNAs containing Mir34a seed-matching sites, which encode proteins related to EMT (epithelial-mesenchymal transition), stemness and Wnt signaling, were enriched after inactivation in adenomas and derived tumoroids. and were characterized as direct targets of Mir34a and Csf1r signaling. -inactivation related expression signatures were associated with CMS4/CRISB+D, stage 4 CRCs and poor patient survival. In tumoroids the loss of conferred resistance to 5-FU which was mediated by . This study provides genetic evidence for a requirement of Mir34a-mediated suppression for intestinal stem/secretory cell homeostasis and tumor suppression, and suggests that therapeutic targeting of CSF1R may be effective for the treatment of CRCs with defects in the p53/miR-34a pathway.

摘要

CSF1 受体(CSF1R)编码 mRNA 是 miR-34a 的直接靶标。然而,miR-34a 对 p53/miR-34a 通路介导的肠道肿瘤抑制的抑制作用的相关性仍然未知。在这里,具有肠上皮细胞(IEC)特异性缺失的小鼠表现出腺瘤形成增加和存活率降低,而缺失则减少了腺瘤的形成并增加了存活率。在腺瘤中,缺失增强了增殖、STAT3 信号传导、成纤维细胞、免疫细胞和微生物的浸润以及肿瘤干细胞的丰度,并降低了细胞凋亡。缺失则产生相反的效果。此外,缺失和的缺失以相反的方式影响肠道分泌细胞和干细胞的平衡以及肿瘤球体的形成。缺失和的同时缺失中和了单个缺失的影响。含有 Mir34a 种子匹配位点的 mRNA,其编码与 EMT(上皮-间质转化)、干细胞特性和 Wnt 信号相关的蛋白质,在腺瘤和衍生的肿瘤球体中失活后被富集。和被表征为 Mir34a 和 Csf1r 信号的直接靶标。与失活相关的表达特征与 CMS4/CRISB+D、CRC 第 4 期和患者预后不良相关。在肿瘤球体中,缺失赋予了对 5-FU 的耐药性,这是由介导的。本研究为 miR-34a 介导的缺失对于肠道干细胞/分泌细胞平衡和肿瘤抑制的需求提供了遗传证据,并表明靶向 CSF1R 的治疗可能对 p53/miR-34a 通路缺陷的 CRC 有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/094caebf85c0/ijbsv18p5415g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/83954c3a4d99/ijbsv18p5415g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/c1082669bc29/ijbsv18p5415g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/4b4669f97b6f/ijbsv18p5415g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/f0ab6bd123e9/ijbsv18p5415g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/3ef2cbfd0fef/ijbsv18p5415g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/ac203ce6a168/ijbsv18p5415g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/1603cb734502/ijbsv18p5415g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/bb9862760699/ijbsv18p5415g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/47efd88d5ea4/ijbsv18p5415g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/094caebf85c0/ijbsv18p5415g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/83954c3a4d99/ijbsv18p5415g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/c1082669bc29/ijbsv18p5415g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/4b4669f97b6f/ijbsv18p5415g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/f0ab6bd123e9/ijbsv18p5415g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/3ef2cbfd0fef/ijbsv18p5415g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/ac203ce6a168/ijbsv18p5415g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/1603cb734502/ijbsv18p5415g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/bb9862760699/ijbsv18p5415g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/47efd88d5ea4/ijbsv18p5415g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/094caebf85c0/ijbsv18p5415g010.jpg

相似文献

1
mediates enhancement of intestinal tumorigenesis caused by inactivation of .介导 APC 失活引起的肠道肿瘤发生增强
Int J Biol Sci. 2022 Aug 29;18(14):5415-5437. doi: 10.7150/ijbs.75503. eCollection 2022.
2
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.结直肠癌中 p53/miR-34a/CSF1R/STAT3 反馈回路的特征。
Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15.
3
and Suppress Intestinal Tumorigenesis.并抑制肠道肿瘤发生。
Cancer Res. 2017 May 15;77(10):2746-2758. doi: 10.1158/0008-5472.CAN-16-2183. Epub 2017 Mar 31.
4
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.p53 和 HIF1A 对 miR-34a 调控 PPP1R11 和 STAT3 及缺氧诱导的结直肠癌细胞上皮间质转化的拮抗作用。
Gastroenterology. 2017 Aug;153(2):505-520. doi: 10.1053/j.gastro.2017.04.017. Epub 2017 Apr 20.
5
CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34.CRISPR/Cas9 介导的 miR-34a 和 miR-34b/c 在 HCT116 结直肠癌细胞中的失活:5-FU 暴露后的综合表征揭示 EMT 和自噬是 miR-34 调控的关键过程。
Cell Death Differ. 2023 Aug;30(8):2017-2034. doi: 10.1038/s41418-023-01193-2. Epub 2023 Jul 24.
6
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.IL-6R/STAT3/miR-34a 反馈环促进 EMT 介导的结直肠癌侵袭和转移。
J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18.
7
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.髓系细胞中的Mir34a抑制结肠炎相关结肠癌:通过单细胞RNA测序对介质进行表征
Cell Death Differ. 2025 Feb;32(2):225-241. doi: 10.1038/s41418-024-01380-9. Epub 2024 Oct 18.
8
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.联合敲除 TP53 和 MIR34A 通过增加 IL6R 和 PAI1 的水平促进小鼠结直肠癌的发生和发展。
Gastroenterology. 2018 Dec;155(6):1868-1882. doi: 10.1053/j.gastro.2018.08.011. Epub 2018 Aug 10.
9
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.p53对c-Kit的抑制作用由miR-34介导,且与化疗耐药性降低、迁移能力及干性相关。
Oncotarget. 2013 Sep;4(9):1399-415. doi: 10.18632/oncotarget.1202.
10
MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.MET 信号转导介导肠道隐窝-绒毛发育、再生和腺瘤形成,并受干细胞 CD44 同种型的促进。
Gastroenterology. 2017 Oct;153(4):1040-1053.e4. doi: 10.1053/j.gastro.2017.07.008. Epub 2017 Jul 14.

引用本文的文献

1
Insights into CSF-1R Expression in the Tumor Microenvironment.对肿瘤微环境中集落刺激因子1受体(CSF-1R)表达的见解。
Biomedicines. 2024 Oct 18;12(10):2381. doi: 10.3390/biomedicines12102381.
2
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.髓系细胞中的Mir34a抑制结肠炎相关结肠癌:通过单细胞RNA测序对介质进行表征
Cell Death Differ. 2025 Feb;32(2):225-241. doi: 10.1038/s41418-024-01380-9. Epub 2024 Oct 18.
3
CSF-1R in Cancer: More than a Myeloid Cell Receptor.癌症中的集落刺激因子1受体:不仅仅是一种髓样细胞受体。

本文引用的文献

1
A rationalized definition of general tumor suppressor microRNAs excludes miR-34a.一个合理化的通用肿瘤抑制 microRNA 的定义排除了 miR-34a。
Nucleic Acids Res. 2022 May 6;50(8):4703-4712. doi: 10.1093/nar/gkac277.
2
Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?类器官与体内小鼠模型:哪种是理解肠上皮生物学机制的更好研究工具?
Cell Mol Gastroenterol Hepatol. 2022;13(1):195-197. doi: 10.1016/j.jcmgh.2021.06.027. Epub 2021 Oct 10.
3
Dependence receptors: new targets for cancer therapy.
Cancers (Basel). 2024 Jan 9;16(2):282. doi: 10.3390/cancers16020282.
依赖受体:癌症治疗的新靶点。
EMBO Mol Med. 2021 Nov 8;13(11):e14495. doi: 10.15252/emmm.202114495. Epub 2021 Sep 20.
4
TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.TAGLN 通过 RhoA/ROCK 通路介导卵巢癌细胞刚性调控的进展。
J Exp Clin Cancer Res. 2021 Sep 19;40(1):292. doi: 10.1186/s13046-021-02091-6.
5
Functions as an Intestinal Tumor Suppressor.作为一种肠道肿瘤抑制因子发挥作用。
Cancer Res. 2021 Jul 1;81(13):3621-3634. doi: 10.1158/0008-5472.CAN-20-4192. Epub 2021 Jun 15.
6
Transgelins: Cytoskeletal Associated Proteins Implicated in the Metastasis of Colorectal Cancer.凝溶胶蛋白:与结直肠癌转移相关的细胞骨架结合蛋白
Front Cell Dev Biol. 2020 Oct 7;8:573859. doi: 10.3389/fcell.2020.573859. eCollection 2020.
7
and High-mobility Group AT-Hook 2 (HMGA2) Complex Regulates TGF-β-induced Colorectal Cancer Metastasis.高迁移率族AT-钩蛋白2(HMGA2)复合物调控转化生长因子-β诱导的结直肠癌转移。
Onco Targets Ther. 2020 Oct 15;13:10489-10498. doi: 10.2147/OTT.S263090. eCollection 2020.
8
Transgelin interacts with PARP1 in human colon cancer cells.在人结肠癌细胞中,凝溶胶蛋白与聚(ADP - 核糖)聚合酶1(PARP1)相互作用。
Cancer Cell Int. 2020 Aug 3;20:366. doi: 10.1186/s12935-020-01461-y. eCollection 2020.
9
Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.软骨寡聚基质蛋白通过与结直肠癌细胞中的 Transgelin 相互作用促进上皮-间充质转化。
Theranostics. 2020 Jul 9;10(19):8790-8806. doi: 10.7150/thno.44456. eCollection 2020.
10
Mir34a constrains pancreatic carcinogenesis.miR34a 抑制胰腺癌细胞生成。
Sci Rep. 2020 Jun 15;10(1):9654. doi: 10.1038/s41598-020-66561-1.